Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fine, P. E. M.
Right arrow Articles by Wamdorff, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fine, P. E. M.
Right arrow Articles by Wamdorff, D. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 146, No. 1: 91-102
Copyright © 1997 by The Johns Hopkins University School of Hygiene and Public Health


research-article

Household and Dwelling Contact as Risk Factors for Leprosy in Northern Malawi

P. E. M. Fine1,, J. A. C. Steme1, J. M. Pönnighaus2,3, L. Bliss1, J. Saul1, A. Chihana2, M. Munthali2 and D. K. Wamdorff2

1Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine London, England
2LEPRA Chilumba, Karonga District, Malawi
3Present address: Dürerstrasse 13 08527 Plauen, Germany

Reprint requests to Dr. P. E. M Fine, Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, England

Data on household and dwelling contact with known leprosy cases were available on more than 80,000 initially disease-free individuals followed up during the 1980s in a rural district of northern Malawi. A total of 331 new cases of leprosy were diagnosed among them. Individuals recorded as living in household or dwelling contact with multibacillary patients at the start of follow-up were at approximately five- to eightfold increased risk of leprosy, respectively, compared with individuals not living in such households or dwellings. Individuals living in household or dwelling contact with paucibacillary cases were both at approximately twofold increased risk. The higher risk associated with multibacillary contact and the fact that dwelling contact entailed a greater risk than household contact if the association was with multibacillary, but not with paucibacillary, disease suggest that paucibacillary cases may not themselves be sources of transmission, but rather just markers that a household has had contact with some (outside) source of infection. When household contact was considered alone, the risks of disease were appreciably higher for younger than for older contacts and for male compared with female contacts. Despite the elevated risk of leprosy associated with household or dwelling contact, only 15% of all incidence cases arose among recognized household contacts. Given the dynamic nature of household membership and consequent misclassification of contact status, the true contribution to overall incidence of contact within household or dwelling settings is likely to be much higher than this, perhaps 30% or higher. Considering the predilection of males for infectious multibacillary forms of the disease, the transmission of Mycobacterium Ieprae at an early age, in particular to males, may be of particular importance for the persistence of leprosy in endemic communities. Although residential contact with a multibacillary case is the strongest known determinant of leprosy risk, the vast majority of such contacts never manifest disease, which indicates a crucial role for genetic and/or environmental factors in the transmission of M. Ieprae infection and/or the pathogenesis of clinical leprosy. Am J Epidemiol 1997;146:91–102.

leprosy; leprosy, transmission


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BMJHome page
F J. Moet, D. Pahan, L. Oskam, J. H Richardus, and for the COLEP Study Group
Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial
BMJ, April 5, 2008; 336(7647): 761 - 764.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
I. M. B. Goulart, D. O. Bernardes Souza, C. R. Marques, V. L. Pimenta, M. A. Goncalves, and L. R. Goulart
Risk and Protective Factors for Leprosy Development Determined by Epidemiological Surveillance of Household Contacts
Clin. Vaccine Immunol., January 1, 2008; 15(1): 101 - 105.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
M. S. Duthie, W. Goto, G. C. Ireton, S. T. Reece, L. P. V. Cardoso, C. M. T. Martelli, M. M. A. Stefani, M. Nakatani, R. C. de Jesus, E. M. Netto, et al.
Use of Protein Antigens for Early Serological Diagnosis of Leprosy
Clin. Vaccine Immunol., November 1, 2007; 14(11): 1400 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
L. R. Kerr-Pontes, M. L Barreto, C. M. Evangelista, L. C Rodrigues, J. Heukelbach, and H. Feldmeier
Socioeconomic, environmental, and behavioural risk factors for leprosy in North-east Brazil: results of a case-control study
Int. J. Epidemiol., August 1, 2006; 35(4): 994 - 1000.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. T. Reece, G. Ireton, R. Mohamath, J. Guderian, W. Goto, R. Gelber, N. Groathouse, J. Spencer, P. Brennan, and S. G. Reed
ML0405 and ML2331 Are Antigens of Mycobacterium leprae with Potential for Diagnosis of Leprosy.
Clin. Vaccine Immunol., March 1, 2006; 13(3): 333 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
L. Zhang, T. Budiawan, and M. Matsuoka
Diversity of Potential Short Tandem Repeats in Mycobacterium leprae and Application for Molecular Typing
J. Clin. Microbiol., October 1, 2005; 43(10): 5221 - 5229.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
M. I. BAKKER, M. HATTA, A. KWENANG, B. H. B. VAN BENTHEM, S. M. VAN BEERS, P. R. KLATSER, and L. OSKAM
PREVENTION OF LEPROSY USING RIFAMPICIN AS CHEMOPROPHYLAXIS
Am J Trop Med Hyg, April 1, 2005; 72(4): 443 - 448.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. I Bakker, M. Hatta, A. Kwenang, W. R Faber, S. M van Beers, P. R Klatser, and L. Oskam
Population survey to determine risk factors for Mycobacterium leprae transmission and infection
Int. J. Epidemiol., December 1, 2004; 33(6): 1329 - 1336.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. T. Douglas, R. V. Cellona, T. T. Fajardo Jr., R. M. Abalos, M. V. F. Balagon, and P. R. Klatser
Prospective Study of Serological Conversion as a Risk Factor for Development of Leprosy among Household Contacts
Clin. Vaccine Immunol., September 1, 2004; 11(5): 897 - 900.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
L. R. S. Kerr-Pontes, A. C. D. Montenegro, M. L. Barreto, G. L. Werneck, and H. Feldmeier
Inequality and leprosy in Northeast Brazil: an ecological study
Int. J. Epidemiol., April 1, 2004; 33(2): 262 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. Matsuoka, L. Zhang, T. Budiawan, K. Saeki, and S. Izumi
Genotyping of Mycobacterium leprae on the Basis of the Polymorphism of TTC Repeats for Analysis of Leprosy Transmission
J. Clin. Microbiol., February 1, 2004; 42(2): 741 - 745.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. Macfarlane, R. Mondragon-Gonzalez, F. Vega-Lopez, B. Wieles, J. de Pena, O. Rodriguez, R. Suarez y de la Torre, R. R. P. de Vries, T. H. M. Ottenhoff, and H. M. Dockrell
Presence of Human T-Cell Responses to the Mycobacterium leprae 45-Kilodalton Antigen Reflects Infection with or Exposure to M. leprae
Clin. Vaccine Immunol., May 1, 2001; 8(3): 604 - 611.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.